Welcome to the international HTA database

Showing [24038 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®) impulse system for acute coronary syndromes including heart attack
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Hyperthermia in breast-, bladder-, cervix carcinoma and soft tissue sarcoma patients
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment for hepatitis C virus infection in adults
2012	National Institute for Health and Care Excellence (NICE)	Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma. NICE technology appraisal guidance 269
2012	National Institute for Health and Care Excellence (NICE)	Partial replacement of the meniscus of the knee using a biodegradable scaffold. NICE interventional procedures guidance 430
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SCOUT DS® and Diab-spot for type 2 diabetes screening
2012	Agency for Healthcare Research and Quality (AHRQ)	Progestogens for prevention of preterm birth
2012	National Institute for Health and Care Excellence (NICE)	Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal). NICE technology appraisal guidance 270
2012	National Institute for Health and Care Excellence (NICE)	Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation. NICE interventional procedures guidance 427
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Periostat for periodontal disease: a review of the clinical effectiveness, cost effectiveness and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Faldaprevir with BI 207127 for chronic hepatitis C infection, genotype 1
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Efficacy and safety of ornithine in treating hyperammonemia from acute and chronic liver diseases]
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for hepatitis C virus infection in adults
2012	National Institute for Health and Care Excellence (NICE)	Focal therapy using cryoablation for localised prostate cancer. NICE interventional procedures guidance 423
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pharmacologic smoking cessation interventions for patients with cardiovascular conditions: a review of the safety and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for active and progressive psoriatic arthritis
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Efficacy and safety of the artificial urinary sphincter (AS) in treating postprostatectomy urinary incontinence]
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2012	National Institute for Health and Care Excellence (NICE)	Micropressure therapy for refractory Ménière's disease. NICE interventional procedures guidance 426
2012	NIHR Health Technology Assessment programme	A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for ankylosing spondylitis – second line
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Efficacy and safety of tocilizumab in treating rheumatoid arthritis]
2012	Agency for Healthcare Research and Quality (AHRQ)	First-generation versus second-generation antipsychotics in adults: comparative effectiveness.
2012	National Institute for Health and Care Excellence (NICE)	Incisionless otoplasty. NICE interventional procedures guidance 422
2012	NIHR Health Technology Assessment programme	Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: Alair® bronchial thermoplasty system for severe asthma
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Uterine artery embolization in patients aiming to preserve the uterus]
2012	Agency for Healthcare Research and Quality (AHRQ)	Drug therapy for rheumatoid arthritis in adults: an update.
2012	National Institute for Health and Care Excellence (NICE)	Breast reconstruction using lipomodelling after breast cancer treatment. NICE interventional procedures guidance 417
2012	NIHR Health Technology Assessment programme	Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dental treatment to correct dental caries in patients undergoing surgery: a review of clinical evidence on safety
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Tofacitinib for moderate to severe chronic plaque psoriasis – second line
2012	HAYES, Inc.	Orthotic compression bracing for treatment of pectus carinatum
2012	Agency for Healthcare Research and Quality (AHRQ)	Drug therapy for psoriatic arthritis in adults: update of a 2007 report.
2012	New Zealand National Health Committee (NHC)	Catheter ablation for the treatment of atrial fibrillation - technology note
2012	NIHR Health Technology Assessment programme	Erlotinib for the first-line treatment of EGFR-TK mutation positive non-small-cell lung cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chlorhexidine gluconate (CHG) for suturing in the emergency room and perineal washing during vaginal deliveries: a review of safety, evidence-based guidelines and recommendations
2012	NIHR Horizon Scanning Centre (NIHR HSC)	ICX-RHY (Vavelta) for recessive dystrophic epidermolysis bullosa –second line
2012	HAYES, Inc.	Percutaneous epidural adhesiolysis for chronic back pain
2012	Agency for Healthcare Research and Quality (AHRQ)	Dietary supplements in adults taking cardiovascular drugs
2012	New Zealand National Health Committee (NHC)	Problem-solving therapy (PST) for people who present to hospital with self-harm - technology note
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dental x-rays and cancer: a review of the evidence on safety
2012	HAYES, Inc.	Percutaneous needle aponeurotomy for Dupuytren contracture
2012	Agency for Healthcare Research and Quality (AHRQ)	Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012	New Zealand National Health Committee (NHC)	Transcatheter Aortic Valve Implantation (TAVI) - briefing report
2012	NIHR Health Technology Assessment programme	Rivaroxaban for the treatment of deep vein thrombosis and secondary prevention of venous thromboembolism
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Composite resin and amalgam dental filling materials: a review of safety, clinical effectiveness and cost-effectiveness
2012	HAYES, Inc.	Pipeline embolization device (Covidien ev3) for treatment of intracranial aneurysms
2012	NIHR Health Technology Assessment programme	Ruxolitinib for the treatment of myelofibrosis
2012	HAYES, Inc.	Phototherapy for early-stage mycosis fungoides
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for adult psychiatric inpatients: a review of clinical evidence and effectiveness
2012	HAYES, Inc.	Plasmapheresis for hypertriglyceridemia-induced pancreatitis
2012	NIHR Health Technology Assessment programme	Eltrombopag for the treatment of chronic immune thrombocytopenic purpura (ITP): a single technology appraisal
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Clopidogrel, prasugrel and ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness, cost effectiveness and guidelines
2012	HAYES, Inc.	Provent sleep apnea therapy (Ventus Medical Inc.)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
2012	HAYES, Inc.	P-Stim (Biegler GmbH) auricular electroacupuncture for pain management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Management and improvement in cancer pain: focusing on narcotic analgesics]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure wound therapy for patients with diabetic foot ulcers and pressure ulcers: a review of the clinical effectiveness
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness study of catheter ablation for atrial fibrillation]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Custom foot orthotics for adults with foot conditions: a review of the clinical and cost effectiveness
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Clinically relevant venous thromboembolism following hip and knee arthroplasty]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Routine dental care programs in long term care: a review of the clinical effectiveness and guidelines
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Costing methods in healthcare]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Prevention of allergy among children]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hydroxocobalamin for cyanide poisoning in the pre-hospital setting: a review of the comparative clinical effectiveness and safety
2012	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[1st Expert Panel on viper venomous bite in Spain]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Research on medical care utilization of stroke patients and related factors in Korea]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Denosumab and zoledronic acid for patients with postmenopausal osteoporosis: a review of the clinical effectiveness, safety, cost effectiveness, and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Impact of day care centres in monitoring patients with Obstructive Sleep Apnea Syndrome (OSAS)]
2012	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on Korean adolescents' risk factors of suicide]
2012	NIHR Health Technology Assessment programme	Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2012	Health Information and Quality Authority (HIQA)	Health technology assessment of a national deep brain stimulation service in Ireland
2012	HAYES, Inc.	Pulmonary thromboendarterectomy for treatment of pulmonary hypertension
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Risk factors at the regional level for suicide in the Korean elderly]
2012	Agency for Healthcare Research and Quality (AHRQ)	Noninvasive technologies for the diagnosis of coronary artery disease in women
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[HIV screening in the general population]
2012	HAYES, Inc.	Qsymia (phentermine/topiramate; Vivus Inc.) for obesity management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	Asian study on the value for a QALY: Korean results
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of health promotion and preventive interventions on nutrition, physical activity, obesity, and sexual health in children and adolescents]
2012	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for percutaneous coronary intervention in coronary artery disease
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis: a review of the comparative clinical efficacy, safety and cost effectiveness
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for colorectal cancer part 1: screening-tests and program design
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in adults
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[List size and quality of care among GPs within The Regular General Practitioner Scheme]
2012	Medical Services Advisory Committee (MSAC)	Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2012	Agency for Healthcare Research and Quality (AHRQ)	Registry of patient registries (RoPR): policies and procedures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in children
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Polysomnography in the diagnosis of sleep-related breathing disorders]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of organisational interventions for mental health services]